Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Cipaglucosidase alfa/miglustat for treating children and adolescents with late-onset Pompe disease	Cipaglucosidase alfa/miglustat (AT-GAA;;Zavesca,;OGT 918;BBDF101)	Pompe disease	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2023	View \| Download
Cladribine for treating relapsing-remitting multiple sclerosis	Cladribine	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Cobolimab with dostarlimab and docetaxel for advanced non-small-cell lung cancer after anti-PD-L1 therapy and chemotherapy	Cobolimab , Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) , Dostarlimab (TSR-042; Jemperli)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Dabrafenib with trametinib for treating metastatic or unresectable BRAF V600 mutation-positive melanoma in adolescents	Dabrafenib (Tafinlar; GSK2118436; dabrafenib mesilate) , Trametinib (Mekinist; TMT212; GSK-1120212B; GSK1120212; JTP-74057; trametinib dimethyl sulfoxide)	Melanoma	Skin Cancer	2023	View \| Download
Dabrafenib with Trametinib with adjuvant therapy for treating advanced BRAF V600 mutation-positive melanoma in adolescents	Dabrafenib (Tafinlar; GSK2118436; dabrafenib mesilate) , Trametinib (Mekinist; TMT212; GSK-1120212B; GSK1120212; JTP-74057; trametinib dimethyl sulfoxide)	Melanoma	Skin Cancer	2023	View \| Download
Dapsone for treating COVID-19	Dapsone (PULM-001;Pulmonem)	COVID-19	Respiratory System	2023	View \| Download
Datopotamab deruxtecan for previously treated advanced non-small-cell lung cancer	Datopotamab deruxtecan (DS-1062)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Datopotamab deruxtecan for previously treated unresectable or metastatic HR+ HER2- breast cancer	Datopotamab deruxtecan (DS-1062)	Breast cancer	Breast Cancer	2023	View \| Download
Degarelix acetate prior to or with radiotherapy for prostate cancer	Degarelix acetate , Radiotherapy	Prostate cancer	Male Reproductive Cancer	2023	View \| Download
Delgocitinib for treating moderate to severe chronic hand eczema after 1 previous therapy	Delgocitinib	Chronic hand eczema	Dermatology	2023	View \| Download